Shares of Cerebras Systems (NASDAQ: CBRS) climbed 4% on Monday as Wall Street research desks published a wave of largely bullish initiation notes. The firms—nine in total—began coverage immediately after Cerebras’ post-IPO quiet period concluded, and each issued a rating effectively equivalent to a Buy.
Across the new research, analysts zeroed in on Cerebras’ wafer-scale hardware design and a backlog of multi-billion-dollar commercial agreements as the core reasons for an optimistic outlook. The dominant theme running through the notes was that Cerebras holds a structural advantage in fast inference - the production use of live AI models - an area analysts say is gaining importance as the compute cycle shifts from training workloads to inference tasks that prioritize speed and real-time reasoning.
Technology and competitive positioning
Cerebras builds the Wafer-Scale Engine (WSE), described in the research as the world’s largest single compute chip. Unlike approaches that tie together thousands of smaller GPUs, Cerebras places extensive SRAM memory directly on a single silicon wafer. Analysts argue this design avoids the latency bottlenecks found in traditional, multi-chip configurations and gives Cerebras a material edge for low-latency inference.
"Cerebras reaches the public market just as the compute cycle pivots from training to inference; the part of the market where speed, not raw FLOPs, dictates output value," noted Wedbush analyst Matt Bryson. He called the setup "asymmetric and upside-skewed."
Market sizing and growth forecasts
Research notes varied on the size of the fast-inference market and its growth trajectory. Barclays analyst Tom O'Malley estimated the fast-inference Total Addressable Market (TAM) could reach $300 billion by the end of the decade. Mizuho offered a more aggressive outlook, projecting the fast-inference segment to expand at a 291% compound annual growth rate to reach roughly $550 billion by 2030.
Commercial validation and contracts
Analysts pointed to two major commercial relationships as validation of Cerebras’ route to scale:
- OpenAI agreement: In January 2026, Cerebras signed a multi-year deal with OpenAI that analysts described as a blockbuster exceeding $20 billion. Under that arrangement, OpenAI is deploying approximately 750MW of Cerebras compute capacity through 2028, with an option to add another 1.25GW. UBS emphasized that Cerebras is currently the only supplier shipping to OpenAI under a pre-payment structure.
- AWS collaboration: In March 2026, Cerebras announced a partnership with Amazon Web Services to support disaggregated inference, offering enterprises an alternate cloud path for ultra-low-latency AI workloads.
Rosenblatt Securities highlighted the revenue inflection implied by these partnerships, noting that Cerebras scaled annual revenue from $25 million in 2022 to $510 million in 2025, and that the firm projects revenue could reach $6.8 billion by 2028.
Analyst coverage and price targets
All nine firms initiating coverage issued favorable outlooks and set price targets that, in aggregate, imply material upside from prevailing market levels. Price targets cited in the new notes ranged from $250.00 to $340.00.
| Investment Bank | Analyst | Rating | Price Target |
|---|---|---|---|
| Citi | Atif Malik | Buy | $340.00 |
| UBS | Timothy Arcuri | Buy | $300.00 |
| Mizuho | Vijay Rakesh | Outperform | $300.00 |
| Needham | N. Quinn Bolton | Buy | $300.00 |
| Rosenblatt | Kevin Cassidy | Buy | $300.00 |
| Barclays | Tom O’Malley | Overweight | $280.00 |
| TD Cowen | Joshua Buchalter | Buy | $275.00 |
| Wedbush | Matt Bryson | Outperform | $270.00 |
| Morgan Stanley | Joseph Moore | Overweight | $250.00 |
Bottom line
Analysts argue that Cerebras combines a proprietary hardware stack that creates a meaningful moat with accelerating revenue projections and anchor customers in AI. The research highlights an expected 122% projected revenue compound annual growth rate through 2029 and foundational commercial support from major AI players. As Morgan Stanley’s Joseph Moore put it, CBRS presents a "unique chance to invest in an AI processor company with a first-mover advantage against NVIDIA."
Investors and market participants will be watching whether the projected revenue trajectory and the company's ability to execute on large-scale deployments materialize in line with the optimistic scenarios laid out by the initiating analysts.
Summary
Cerebras' stock rose after nine brokerages began coverage following the end of its post-IPO quiet period. Analysts cited wafer-scale architecture, fast-inference advantages, and major contracts with OpenAI and AWS as key reasons for bullish ratings and high price targets.